Cite
Effect of glucocorticoids on the development of COVID‐19‐associated pulmonary aspergillosis: A meta‐analysis of 21 studies and 5174 patients.
MLA
Hashim, Zia, et al. “Effect of Glucocorticoids on the Development of COVID‐19‐associated Pulmonary Aspergillosis: A Meta‐analysis of 21 Studies and 5174 Patients.” Mycoses, vol. 66, no. 11, Nov. 2023, pp. 941–52. EBSCOhost, https://doi.org/10.1111/myc.13637.
APA
Hashim, Z., Nath, A., Khan, A., Gupta, M., Kumar, A., Chatterjee, R., Dhiman, R. K., Hoenigl, M., & Tripathy, N. K. (2023). Effect of glucocorticoids on the development of COVID‐19‐associated pulmonary aspergillosis: A meta‐analysis of 21 studies and 5174 patients. Mycoses, 66(11), 941–952. https://doi.org/10.1111/myc.13637
Chicago
Hashim, Zia, Alok Nath, Ajmal Khan, Mansi Gupta, Anup Kumar, Riksoam Chatterjee, Radha Krishan Dhiman, Martin Hoenigl, and Naresh Kumar Tripathy. 2023. “Effect of Glucocorticoids on the Development of COVID‐19‐associated Pulmonary Aspergillosis: A Meta‐analysis of 21 Studies and 5174 Patients.” Mycoses 66 (11): 941–52. doi:10.1111/myc.13637.